Drug Trial Radar · NCT00535587
Testing Mestinon and Exercise in Fibromyalgia
Last checked: Nov 19, 2026Latest source record: Apr 18, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
178
Actual
Start
Sep 2002
Primary completion
Jun 2008
Study completion Jun 2008
Sponsor
- Lead sponsor
- Oregon Health and Science UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Nursing Research (NINR)
- First posted
- Sep 26, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial was to test the combined and independent effects of 6 months of exercise and Mestinon in people with fibromyalgia. Specifically, we wanted to determine if Mestinon helped people with fibromyalgia have an easier time exercising and if their symptoms improved by the end of the trial.
Conditions
- Fibromyalgia
Interventions
ExerciseBehavioral
pyridostigmineDrug
PlaciboDrug
Attention ControlBehavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Levels of Growth Hormone Post ExerciseTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Oregon Health & Science University
Portland, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.